Applicants are selected by the ACLI Selection Committee based on their potential to develop as global leaders in biomedical research, healthcare, industry, community engagement, advocacy, governmental liaison, or other critical areas of need for leadership in Africa. Membership in AORTIC and potential to take on a future leadership role in the Organization and/or other Africa based Institutions/Organizations focused on Cancer are major criteria for selection. We encourage applications from women, members of underserved and communities under-represented in research, and persons with disabilities. We will promote Diversity, Equity and Inclusion in the ACLI cohort in compliance with the Guidelines for Inclusion of Women, Minorities, and Persons with Disabilities in NIH-Supported Conference Grants policy.
Successful candidates for the ACLI will be individuals who show promise to lead initiatives and activities related to patient-centered cancer research in Africa. Ideal candidates are at junior to mid- level in their careers with demonstrable leadership experience. Special consideration will be given to those individuals who are involved in patient care or engaged in patient-oriented research relevant to Africa, or planning to apply for NIH research training grants or career development awards like K01/K08/K23/K43/K99/R01 and/or can provide a rationale for how they will contribute to the development of high-quality interdisciplinary and interprofessional cancer care in Africa. Candidates will be encouraged to demonstrate their interest and ability to commit to AORTIC and cancer leadership activities over the long term. African Cancer Leaders Institute will be particularly suitable for awardees of K43 Global Leadership Awards and Beginner Investigator Grant for Catalytic Research (BIGCAT) awards from the NCI.
The target audience for AORTIC includes physicians (oncologists, gastroenterologists, gynecologists, primary care physicians and surgeons), scientists, nurses, physician assistants and pharmacists from community and academic practices in Africa. However, International AORTIC participants have come from countries in Europe, North America, Middle East and the UK to mention a few. Through this funding mechanism, ACLI will provide special incentives for senior leaders to invite their junior investigators/emerging leaders to attend AORTIC and participate in ACLI. Long-term, it is expected that AORTIC will create a community of Emerging Leaders to drive innovations to provide high quality cancer care in Africa through research.